Market Highlights
Infectious diseases can be caused by bacteria, viruses, fungi, and parasites. Some of the common examples of infectious diseases are acquired immunodeficiency syndrome (AIDS), hepatitis B, tuberculosis (TB), and others. Increasing prevalence of the infectious diseases like TB, AIDS is one of the major drivers for the growth of the market during the forecast period. According to the World Health Organization, in 2016, HIV/AIDS affected 36.7 million people, causing 1.0 million deaths across the globe. Additionally, increasing healthcare expenditures and growing awareness of infectious diseases among the patients will boost the market growth during the forecast period. However, low adoption of the treatment and low per capita healthcare expenditure in the developing economies may restrain the market growth during the forecast period.
The global infectious disease treatments market is expected to grow at an approximate CAGR of 7.1% during the forecast period.
Segmentation
The global infectious disease treatments market is segmented on the basis of type, treatment, and end-users.
Based on the kind, the market is divided into viral diseases, bacterial diseases, and others. The viral diseases fragment is sub-divided into (AIDS), hepatitis B, hepatitis C, and others. The bacterial diseases fragment is sub-divided into tuberculosis (TB), bacterial meningitis, and others.
Based on the treatment, the market is divided into antibacterial medications, antifungal medications, antiviral medications, hostile to parasitic medications, and others. The antibacterial medications fragment is sub-divided into beta-lactams, quinolones, sulfonamides, antibiotic medications, and others. The antifungal medications fragment is sub-divided into azoles, pyrimidines, echinodians, polyenes, and others.
Based on the application, the market is divided into asthma, persistent obstructive aspiratory disease (COPD), cystic fibrosis, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, research organization, retail pharmacies, and others.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1626
Regional Analysis
The Americas rule the worldwide infectious disease treatments market attributable to an all around created medical services area and enormous patient populace. Additionally, expanding medical services consumption followed by changing way of life drives the market development in the Americas.
Europe is the second biggest infectious disease treatments market. High medical services uses, government support for research and advancement, and colossal patient populace drives the European market.
Asia Pacific is the quickest developing locale in the worldwide market because of the presence of a colossal patient populace and constantly creating economies like India and China. Then again, the Middle East and Africa holds minimal offer in the worldwide infectious disease treatments market because of the presence of unfortunate economies in the African area. A larger part of the Middle East and Africa market is held by the Middle East.
Key Players
Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.K), AstraZeneca (U.K), Novartis AG (Switzerland), Sanofi (France), Mylan N.V. (U.S.), and others are some of the key players for the global infectious disease treatments market.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/infectious-disease-treatments-market-1626
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments